PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.\', \'Cedars-Sinai Biomanufacturing Center, Cedars-Sinai Medical Center, Los Angeles, CA, United States.\', \'Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, United States.\', \'Genomics Core, Cedars-Sinai Medical Center, Los Angeles, CA, United States.\', \'Biobank and Translational Research Core, Samuel Oschin Comprehensive Cancer Institute (SOCCI), Cedars-Sinai Medical Center, Los Angeles, CA, United States.\', \'Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States.\', \'Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States.\', \'Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, Los Angeles, CA, United States.\', \'iPSC Core, David and Janet Polak Foundation Stem Cell Core Laboratory, Cedars-Sinai Medical Center, Los Angeles, CA, United States.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fcimb.2021.678482
?:hasPublicationType
?:journal
  • Frontiers in cellular and infection microbiology
is ?:pmid of
?:pmid
?:pmid
  • 34282405
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.703
?:rankingScore_hIndex
  • 43
is ?:relation_isRelatedTo_publication of
?:title
  • Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all